USPH Net Income vs Free Cash Flow Analysis

USPH Stock

USD 90.26 0.42 0.47%

US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Net Income and its Free Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Net Income vs Free Cash Flow

Net Income vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Net Income account and Free Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between US Physicalrapy's Net Income and Free Cash Flow is 0.49. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Net Income and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of US Physicalrapy are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Net Income i.e., US Physicalrapy's Net Income and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.49

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in US Physicalrapy financial statement analysis. It represents the amount of money remaining after all of US Physicalrapy operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 20.15, while Selling General Administrative is projected to decrease to under 26.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	117.2M	112.0M	112.0M	117.6M
Total Revenue	495.0M	553.1M	604.8M	635.0M

Gross Profit Total Revenue

US Physicalrapy fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Non Currrent Assets Other	Non Current Liabilities Total	Short Term Debt	Intangible Assets	Good Will	Common Stock Total Equity	Common Stock
Total Assets		-0.01	0.96	0.98	0.94	0.77	0.91	0.78	0.8	0.99	0.8	0.54	0.71	0.93	0.79	0.98	0.94	0.91	0.95	-0.35	0.95	0.93	0.99	-0.41	0.55	0.56
Other Current Liab	-0.01		0.02	0.06	-0.14	-0.3	0.23	-0.28	-0.09	-0.02	-0.09	0.6	0.44	-0.33	0.08	-0.19	-0.24	-0.01	-0.26	0.41	-0.26	-0.26	-0.08	-0.5	0.5	0.5
Total Current Liabilities	0.96	0.02		0.93	0.96	0.75	0.89	0.7	0.74	0.97	0.74	0.5	0.67	0.89	0.69	0.94	0.92	0.84	0.91	-0.32	0.88	0.96	0.93	-0.38	0.51	0.52
Total Stockholder Equity	0.98	0.06	0.93		0.87	0.63	0.89	0.67	0.89	0.95	0.89	0.51	0.75	0.9	0.88	0.92	0.91	0.97	0.89	-0.18	0.88	0.88	0.95	-0.46	0.6	0.61
Property Plant And Equipment Net	0.94	-0.14	0.96	0.87		0.85	0.84	0.77	0.68	0.95	0.68	0.45	0.58	0.89	0.59	0.95	0.94	0.78	0.95	-0.43	0.92	0.97	0.91	-0.29	0.42	0.43
Net Debt	0.77	-0.3	0.75	0.63	0.85		0.74	0.92	0.32	0.82	0.32	0.49	0.47	0.78	0.27	0.87	0.78	0.48	0.89	-0.8	0.89	0.81	0.81	-0.26	0.35	0.36
Retained Earnings	0.91	0.23	0.89	0.89	0.84	0.74		0.75	0.58	0.92	0.58	0.76	0.88	0.78	0.63	0.87	0.78	0.75	0.82	-0.39	0.83	0.79	0.89	-0.7	0.79	0.8
Accounts Payable	0.78	-0.28	0.7	0.67	0.77	0.92	0.75		0.4	0.81	0.4	0.49	0.55	0.82	0.4	0.86	0.73	0.56	0.87	-0.81	0.89	0.75	0.82	-0.38	0.46	0.46
Cash	0.8	-0.09	0.74	0.89	0.68	0.32	0.58	0.4		0.74	1.0	0.15	0.49	0.8	0.95	0.73	0.81	0.97	0.71	0.14	0.7	0.74	0.76	-0.2	0.34	0.35
Non Current Assets Total	0.99	-0.02	0.97	0.95	0.95	0.82	0.92	0.81	0.74		0.74	0.57	0.7	0.91	0.73	0.98	0.93	0.86	0.96	-0.43	0.96	0.94	0.99	-0.41	0.55	0.55
Cash And Short Term Investments	0.8	-0.09	0.74	0.89	0.68	0.32	0.58	0.4	1.0	0.74		0.15	0.49	0.8	0.95	0.73	0.81	0.97	0.71	0.14	0.7	0.74	0.76	-0.2	0.34	0.35
Net Receivables	0.54	0.6	0.5	0.51	0.45	0.49	0.76	0.49	0.15	0.57	0.15		0.85	0.31	0.3	0.48	0.36	0.35	0.43	-0.29	0.45	0.32	0.53	-0.74	0.83	0.83
Common Stock Shares Outstanding	0.71	0.44	0.67	0.75	0.58	0.47	0.88	0.55	0.49	0.7	0.49	0.85		0.57	0.59	0.63	0.55	0.65	0.58	-0.16	0.59	0.52	0.67	-0.9	0.98	0.98
Other Current Assets	0.93	-0.33	0.89	0.9	0.89	0.78	0.78	0.82	0.8	0.91	0.8	0.31	0.57		0.74	0.96	0.95	0.87	0.96	-0.43	0.95	0.95	0.93	-0.3	0.42	0.43
Other Stockholder Equity	0.79	0.08	0.69	0.88	0.59	0.27	0.63	0.4	0.95	0.73	0.95	0.3	0.59	0.74		0.69	0.72	0.95	0.65	0.13	0.66	0.64	0.77	-0.32	0.45	0.46
Total Liab	0.98	-0.19	0.94	0.92	0.95	0.87	0.87	0.86	0.73	0.98	0.73	0.48	0.63	0.96	0.69		0.96	0.84	0.99	-0.5	0.99	0.96	0.98	-0.34	0.47	0.48
Property Plant And Equipment Gross	0.94	-0.24	0.92	0.91	0.94	0.78	0.78	0.73	0.81	0.93	0.81	0.36	0.55	0.95	0.72	0.96		0.88	0.96	-0.31	0.95	0.96	0.93	-0.24	0.38	0.39
Total Current Assets	0.91	-0.01	0.84	0.97	0.78	0.48	0.75	0.56	0.97	0.86	0.97	0.35	0.65	0.87	0.95	0.84	0.88		0.82	-0.01	0.81	0.81	0.88	-0.36	0.5	0.51
Short Long Term Debt Total	0.95	-0.26	0.91	0.89	0.95	0.89	0.82	0.87	0.71	0.96	0.71	0.43	0.58	0.96	0.65	0.99	0.96	0.82		-0.53	1.0	0.95	0.96	-0.29	0.42	0.43
Non Currrent Assets Other	-0.35	0.41	-0.32	-0.18	-0.43	-0.8	-0.39	-0.81	0.14	-0.43	0.14	-0.29	-0.16	-0.43	0.13	-0.5	-0.31	-0.01	-0.53		-0.55	-0.42	-0.44	0.09	-0.11	-0.12
Non Current Liabilities Total	0.95	-0.26	0.88	0.88	0.92	0.89	0.83	0.89	0.7	0.96	0.7	0.45	0.59	0.95	0.66	0.99	0.95	0.81	1.0	-0.55		0.93	0.97	-0.31	0.44	0.45
Short Term Debt	0.93	-0.26	0.96	0.88	0.97	0.81	0.79	0.75	0.74	0.94	0.74	0.32	0.52	0.95	0.64	0.96	0.96	0.81	0.95	-0.42	0.93		0.92	-0.21	0.35	0.36
Intangible Assets	0.99	-0.08	0.93	0.95	0.91	0.81	0.89	0.82	0.76	0.99	0.76	0.53	0.67	0.93	0.77	0.98	0.93	0.88	0.96	-0.44	0.97	0.92		-0.36	0.5	0.51
Good Will	-0.41	-0.5	-0.38	-0.46	-0.29	-0.26	-0.7	-0.38	-0.2	-0.41	-0.2	-0.74	-0.9	-0.3	-0.32	-0.34	-0.24	-0.36	-0.29	0.09	-0.31	-0.21	-0.36		-0.97	-0.97
Common Stock Total Equity	0.55	0.5	0.51	0.6	0.42	0.35	0.79	0.46	0.34	0.55	0.34	0.83	0.98	0.42	0.45	0.47	0.38	0.5	0.42	-0.11	0.44	0.35	0.5	-0.97		1.0
Common Stock	0.56	0.5	0.52	0.61	0.43	0.36	0.8	0.46	0.35	0.55	0.35	0.83	0.98	0.43	0.46	0.48	0.39	0.51	0.43	-0.12	0.45	0.36	0.51	-0.97	1.0

Click cells to compare fundamentals

US Physicalrapy Account Relationship Matchups

US Physicalrapy fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	560.8M	594.4M	749.4M	858.2M	997.2M	1.0B
Other Current Liab	30.9M	26.5M	12.5M	3.4M	18.7M	11.7M
Total Current Liabilities	60.6M	93.5M	83.5M	85.5M	102.2M	107.3M
Total Stockholder Equity	240.3M	276.2M	295.6M	315.8M	476.2M	500.0M
Property Plant And Equipment Net	103.7M	103.3M	119.4M	127.8M	129.5M	136.0M
Net Debt	114.3M	78.1M	194.5M	263.7M	105.8M	111.1M
Retained Earnings	184.4M	212.0M	223.6M	232.9M	223.8M	235.0M
Accounts Payable	2.5M	1.3M	6.5M	6.5M	3.9M	4.1M
Cash	23.5M	32.9M	28.6M	31.6M	152.8M	160.5M
Non Current Assets Total	475.5M	506.7M	654.3M	746.9M	763.9M	802.1M
Cash And Short Term Investments	23.5M	32.9M	28.6M	31.6M	152.8M	160.5M
Net Receivables	56.1M	41.9M	46.3M	51.9M	51.9M	27.3M
Common Stock Shares Outstanding	12.8M	12.8M	12.9M	13.0M	14.2M	12.9M
Liabilities And Stockholders Equity	560.8M	594.4M	749.4M	858.2M	997.2M	1.0B
Other Current Assets	5.8M	12.8M	20.3M	27.7M	28.7M	30.1M
Other Stockholder Equity	55.8M	64.0M	71.1M	78.7M	249.5M	261.9M
Total Liab	181.4M	184.4M	297.0M	373.6M	345M	362.3M
Property Plant And Equipment Gross	103.7M	103.3M	97.9M	208.0M	214.4M	225.1M
Total Current Assets	85.4M	87.6M	95.2M	111.3M	233.4M	245.0M
Short Long Term Debt Total	137.8M	111.0M	223.1M	295.3M	258.6M	271.5M
Non Currrent Assets Other	1.5M	1.5M	(28.7M)	(26.4M)	2.8M	3.0M
Non Current Liabilities Total	120.8M	90.9M	213.5M	288.1M	242.8M	255.0M
Short Term Debt	27.2M	59.9M	61.8M	75.3M	78.2M	82.1M
Intangible Assets	52.6M	56.3M	86.4M	108.8M	109.7M	115.2M
Good Will	317.7M	345.6M	434.7M	494.1M	509.6M	484.1M
Common Stock Total Equity	148K	149K	150K	151K	173.7K	144.3K
Common Stock	149K	150K	151K	152K	172K	147.0K
Other Assets	1.5M	14.1M	1.6M	1.6M	1.9M	2.1M
Long Term Debt	50.4M	16.6M	117.6M	175.8M	139.0M	145.9M
Property Plant Equipment	22.1M	21.7M	119.4M	127.8M	146.9M	154.3M
Other Liab	10.2M	12.3M	21.7M	34.3M	39.5M	41.5M
Net Tangible Assets	7.7M	6.6M	(225.5M)	(287.1M)	(258.4M)	(245.4M)
Noncontrolling Interest In Consolidated Entity	930K	1.4M	1.5M	1.6M	1.4M	1.3M
Retained Earnings Total Equity	167.4M	184.4M	212.0M	224.4M	258.1M	158.3M
Long Term Debt Total	38.4M	50.4M	16.6M	117.6M	135.2M	142.0M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Dividend Share

1.75

Earnings Share

0.88

Revenue Per Share

42.489

Quarterly Revenue Growth

0.12

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

USPH Net Income vs Free Cash Flow Analysis

Net Income vs Free Cash Flow

Net Income vs Free Cash Flow Correlation Analysis

Correlation Coefficient

Net Income

Free Cash Flow

US Physicalrapy fundamental ratios Correlations

US Physicalrapy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

US Physicalrapy fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Assets Total	+ 0.99	Total Assets
Intangible Assets	+ 0.99	Total Assets
Intangible Assets	+ 0.99	Non Current Assets Total

Common Stock	- 0.97	Good Will
Common Stock Total Equity	- 0.97	Good Will
Good Will	- 0.9	Common Stock Shares Outstanding
Non Currrent Assets Other	- 0.81	Accounts Payable
Non Currrent Assets Other	- 0.8	Net Debt
Good Will	- 0.74	Net Receivables